Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martin Winkler and Björn Tampe.
Martin Winkler
Connection Strength
2.116
Björn Tampe
  1. Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'. Ann Rheum Dis. 2020 Sep 21.
    View in: PubMed
    Score: 0.904
  2. Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study. Front Med (Lausanne). 2021; 8:644715.
    View in: PubMed
    Score: 0.237
  3. Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab'. Ann Rheum Dis. 2021 May 12.
    View in: PubMed
    Score: 0.236
  4. Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'. Ann Rheum Dis. 2021 Jan 07.
    View in: PubMed
    Score: 0.231
  5. Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation. Crit Care Explor. 2020 Nov; 2(11):e0284.
    View in: PubMed
    Score: 0.228
  6. Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia. Ann Rheum Dis. 2020 Jul 15.
    View in: PubMed
    Score: 0.223
  7. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021 02; 24(2):168-175.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.